Navigation Links
New research examines care practices in place for dialysis patients
Date:6/8/2010

CINCINNATIResearchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs (VA) Medical Center have received funding to study the care processes that lead to placement of arteriovenous fistulas in patients beginning dialysis.

Timmy Lee, MD, UC Health nephrologist, staff VA physician and lead investigator on the study, was awarded the National Kidney Foundation's Young Investigator Awardtotaling $150,000 over three yearsto look at ways to improve access placement in patients starting dialysis for the first time.

"There are two main types of permanent dialysis access: an arteriovenous fistula (AVF), which connects the artery and the vein directly, and an arteriovenous graft, which connects the artery and the vein using a plastic tube," he says. "AVFs are the best form of access because fewer interventions are needed in order to keep the access area open once functional, and fewer infections occur compared to grafts; however, less than 20 percent of dialysis patients use AVFs on their first dialysis session. National guidelines are seeking to achieve a goal of 50 percent of patients starting dialysis with a functional AVF.

"In this observational study, we will examine the processes of care that get patients to the point of having an AVF implanted when they start dialysis, such as early referral from a patient's internist to their nephrologist and physicians' discussions with patients about dialysis options, time of examination of their veins and arteries with ultrasound, referral to a surgeon for fistula placement, and placement of a fistula before dialysis is needed."

Nephrologists and surgeons at the VA will also initiate a multi-disciplinary clinic to deliver comprehensive care to patients with advanced chronic kidney disease. These nephrologists and surgeons are already operating a vascular access clinic at the VA.

Lee says both of these initiatives will be examined for their effect on improving the rate of successful placement of preferred vascular access, and researchers will compare historical data with the results from the initiation of these two new clinics.

This project will be completed at the VA.

"We will look at the level of kidney function when preoperative ultrasound mapping occursa tool which allows physicians to look at the vessel size to determine if an AVF is the right fit for the patientand level of kidney function when surgeon referral and surgical placement occurs," he says. "We're specifically trying to pinpoint a breakdown in the steps to see if it can be prevented. Furthermore, we believe that these newly developed clinics will improve processes of care measures."

"We hope that this research and our patient care clinics dedicated to vascular access care will greatly improve results for this subgroup," he continues. "There are over 450,000 people undergoing hemodialysis in the United States. If we tweak the way we are doing things to prevent the need for added surgeries and interventions, we will be positively impacting lives all over the world."


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. Research shows personality can predict fertility
2. Simple eye test measures damage from multiple sclerosis, UT Southwestern researchers find
3. Sung-Cheng (Henry) Huang receives 2010 Benedict Cassen Prize for Research in Nuclear Medicine
4. B2Discovery: Entrepreneurs and researchers join forces to conquer cancer
5. Researchers Report Treatment Headway Against Lung Cancer
6. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
7. MSU researchers discover potential genetic factor in eating disorders
8. AACR Adds to Growing STAR P-2 trial; Publishes Update and Perspectives in Cancer Prevention Research
9. Mount Sinai researchers approaching universal treatment for all strains of influenza
10. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
11. HIRC Research Alert: Health Plans Expected to Increase Adoption of Percent Copays to Manage Specialty Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: